Biotechnologies play an essential role for the delivery of EU objectives for competitive, healthy, resilient and sustainable economies and societies. Future-proofing fundamental frameworks across all biotech applications including healthcare, agri-food supply chains, manufacturing processes, chemicals and consumer goods, is critical. EuropaBio welcomes the Commission’s commitment to an EU Biotech Act with a broad scope covering all biotech applications, and acknowledgement of the biotech industries as key competitiveness and security drivers.

In the current challenging trade and geopolitical environment, the Biotech Act must serve to maximise Europe’s global impact and strategic leadership in biotech and biomanufacturing, whilst enhancing competitiveness and economic security. Current regulatory barriers must be resolved urgently through a dedicated Biotech Omnibus Package followed by a forward-looking EU Biotech Act to build the next generation ecosystem. This should be further amplified through other initiatives, including the EU Life Sciences Strategy, Bioeconomy Strategy and Clean Industrial Deal, illustrated by the legislative cluster (Annex).

Read and download the full position below